Belmont, CA · Founded 2021 · Privately Held (backing)
Operator of a drug development platform intended to develop novel antibody-drug conjugates. Solve Therapeutics is based in Belmont, CA and was founded in 2021. It was valued at $439 million at its early-stage round in Nov 2025, the last priced event on record. It has raised $385 million across 3 recorded rounds; the latest was a $48.2 million early-stage round in Nov 2025.
PMV mark · valuation
$439.0M
Oct 2026
Priced at
its early-stage round
Nov 2025
Total raised
$384.5M
Last round
Early Stage VC
Nov 2025
Team — not yet on record
No current team members for Solve Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Solve Therapeutics with a free account
·The complete investor list: 16 names
·Watch Solve Therapeutics: the Monday email on marks, rounds and moves
